Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02842658 · ClinicalTrials.gov registry record · NA

Exercise Preconditioning and Breast Cancer Cardiotoxicity

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT02842658: Completed NA study, sponsored by Mayo Clinic.

NCT02842658 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02842658, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a supervised exercise-training program, initiated prior to chemotherapy induction (pre-conditioning) and continued throughout chemotherapy treatment, can preserve short- and long-term cardiovascular performance, skeletal muscle function, cognitive ability and quality of life better than current standard or care recommendations for exercise during chemotherapy.

Interventions

  • OTHER A high-intensity interval exercise group
  • OTHER An Attention-Control Group

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2016-04
Est. Completion 2019-10-18
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT02842658

The ClinicalTrials.gov registry entry for NCT02842658 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which A high-intensity interval exercise group is the first listed.

NCT02842658 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02842658 about?

NCT02842658 is a clinical study titled "Exercise Preconditioning and Breast Cancer Cardiotoxicity". The purpose of this study is to determine whether a supervised exercise-training program, initiated prior to chemotherapy induction (pre-conditioning) and continued throughout chemotherapy treatment, can preserve short- and long-term cardiovascular performance, skeletal muscle function, cognitive ab...

What is the current status of trial NCT02842658?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2016-04. Estimated completion is 2019-10-18.

What interventions are being tested in trial NCT02842658?

The interventions under investigation include: A high-intensity interval exercise group (OTHER), An Attention-Control Group (OTHER).

Who is sponsoring clinical trial NCT02842658?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.